In one of the largest settlements of its kind, Idaho will receive nearly $1 million as part of a $68.5 million agreement with the manufacturers of Seroquel, used to treat Alzheimer's, dementia and depression.
Idaho will receive $997,000 from AstraZeneca Pharmaceuticals and its parent company that resolves alleged unlawful marketing of Seroquel, used most commonly in nursing homes.…
[ Read more ]